Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03871959
Title Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma (CATRIPCA)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications

pancreatic ductal adenocarcinoma

colorectal cancer

Therapies

Pembrolizumab + Xevinapant

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST